A pilot study using electronic reminders for amblyopia treatment

References

• Hashemi H, Pakzad R, Yekta A, et al. Global and regional estimates of prevalence of amblyopia: a systematic review and meta-analysis. Strabismus. 2018;Jul 30:1–16. doi:10.1080/09273972.2018.1500618.
   Web of Science ®Google Scholar
• Cotter SA, Foster NC, Homes JM, et al. Optical treatment of strabismic and combined strabismic-ansiometropic amblyopia. Ophthalmology. 2012;119:150. doi:10.1016/j.ophtha.2011.06.043.
   PubMed Web of Science ®Google Scholar
• Moseley MJ, Wallace MP, Stephens DA, et al. Personalized versus standardized dosing strategies for the treatment of childhood amblyopia: study protocol for a randomized controlled trial. Trials. 2015;16:189. doi:10.1080/09273972.2016.1242638.
   PubMed Web of Science ®Google Scholar
• Woodruff G, Hiscox F, Thompson JR, Smith LK. Factors affecting the outcome of children treated for amblyopia. Eye. 1994;8:627. doi:10.1038/eye.1994.157.
   PubMed Web of Science ®Google Scholar
• Menon V, Chaudhuri Z, Saxena R, et al. Factors influencing visual rehabilitation after occlusion therapy in unilateral amblyopia in children. Indian J Med Res. 2005;122(6):497.
   PubMed Web of Science ®Google Scholar
• Stewart CE, Moseley MJ, Georgiou P, Fielder AR. Occlusion dose monitoring in amblyopia therapy: status, insights, and future directions. J Aapos. 2017;21:402. doi:10.1016/j.jaapos.2017.06.018.
   PubMed Web of Science ®Google Scholar
• Searle A, Norman P, Harrad R, Vedhara K. Psychosocial and clinical determinants of compliance with occlusion therapy for amblyopic children. Eye. 2002;16:150. doi:10.1038/sj/eye/6700086.
   PubMed Web of Science ®Google Scholar
• Loudon SE, Passchier J, Chaker L, et al. Psychological causes of non-compliance with electronically monitored occlusion therapy for amblyopia. Br J Ophthalmol. 2009;93:1499. doi:10.1136/bjo.2008.149815.
   PubMed Web of Science ®Google Scholar
• Choong YF, Lukman H, Martin S, Laws DE. Childhood amblyopia treatment: psychosocial implications for patients and primary carers. Eye. 2004;18:369. doi:10.1038/sj.eye.6700647.
   PubMed Web of Science ®Google Scholar
• Dean SE, Povey RC, Reeves J. Assessing interventions to increase compliance to patching treatment in children with amblyopia: a systematic review and meta-analysis. Br J Ophthalmol. 2016;100:159. doi:10.1136/bjophthalmol-2015-307340.
   PubMed Web of Science ®Google Scholar
• Wallace MP, Stewart CE, Moseley MJ, et al. Compliance with occlusion therapy for childhood amblyopia. Invest Ophthalmol Vis Sci. 2013;54:6158. doi:10.1167/iovs.13-11861.
   PubMed Web of Science ®Google Scholar
• Holmes JM, Strauber S, Quinn GE, et al. Further validation of the Amblyopia Treatment Index parental questionnaire. J Aapos. 2008;12:581. doi:10.1016/j.jaapos.2008.04.017.
   PubMed Web of Science ®Google Scholar
• Holmes JM, Beck RW, Kraker RT, et al. Impact of patching and atropine treatment on the child and family in the amblyopia treatment study. Arch Ophthalmol. 2003;121(11):1625–1632. doi:10.1001/archopht.121.11.1625.
   PubMedGoogle Scholar
• Okeke CO, Quigley HA, Jampel HD, et al. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology. 2009;116:2286. doi:10.1016/j.ophtha.2009.05.026.
   PubMed Web of Science ®Google Scholar
• Hou MY, Hurwitz S, Kavanagh E, et al. Using daily text-message reminders to improve adherence with oral contraceptives: a randomized controlled trial. Obstet Gynecol. 2010;116:633. doi:10.1097/AOG.0b013e3181eb6b0f.
   PubMed Web of Science ®Google Scholar
• Stewart CE, Moseley MJ, Stephens DA, Fielder AR. Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Invest Ophthalmol Vis Sci. 2004;45:3048.
   PubMed Web of Science ®Google Scholar
• Wang J. Compliance and patching and atropine amblyopia treatments. Vision Res. 2015;114:31. doi:10.1016/j.visres.2015.02.012.
   PubMed Web of Science ®Google Scholar
• Al-Zuhaibi S, Al-Harthi I, Cooymans P, et al. Compliance of amblyopic patients with occlusion therapy: a pilot study. Oman J Ophthalmol. 2009;2:67. doi:10.4103/0974-620X.53035.
   PubMedGoogle Scholar
• Loudon SE, Fronius M, Looman CW, et al. Predictors and a remedy for noncompliance with amblyopia therapy in children measured with the occlusion dose monitor. Invest Ophthalmol Vis Sci. 2006;47:4393. doi:10.1167/iovs.05-1428.
   PubMed Web of Science ®Google Scholar
• Dayer L, Heldenbrand S, Anderson P, et al. Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc. 2013;53:172. doi:10.1331/JAPhA.2013.12202.
   Google Scholar
• Simonsz HJ, Polling JR, Voorn R, et al. Electronic monitoring of treatment compliance in patching for amblyopia. Strabismus. 1999;7:113. doi:10.1076/stra.7.2.113.645.
   PubMedGoogle Scholar
• Orrell C, Cohen K, Mauff K, et al. A randomized controlled trial of real-time electronic adherence monitoring with text message dosing reminders in people starting first-line antiretroviral therapy. J Acquir Immune Defic Syndr. 2015;70:495. doi:10.1097/QAI.0000000000000770.
   PubMed Web of Science ®Google Scholar
• Fang R, Li X. Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study. J Clin Nurs. 2016;25:664. doi:10.1111/jocn.12988.
   PubMed Web of Science ®Google Scholar
• Koshy E, Car J, Majeed A. Effectiveness of mobile-phone short message service (SMS) reminders for ophthalmology outpatient appointments: observational study. BMC Ophthalmol. 2008;8:9. doi:10.1186/1471-2415-8-9.
   PubMed Web of Science ®Google Scholar
• Lin H, Chen W, Luo L, et al. Effectiveness of a short message reminder in increasing compliance with pediatric cataract treatment: a randomized trial. Ophthalmology. 2012;119:2463. doi:10.1016/j.ophtha.2012.06.046.
   PubMed Web of Science ®Google Scholar
• Abu Hussein NB, Eissa IM, Abdel-Kader AA. Analysis of factors affecting patients’ compliance to topical antiglaucoma medications in Egypt as a developing country model. J Ophthalmol. 2015; epub: doi doi:10.1155/2015/234157.
   PubMed Web of Science ®Google Scholar
• Boden C, Sit A, Weinreb RN. Accuracy of an electronic monitoring and reminder device for use with Travoprost eye drops. J Glaucoma. 2006;15:30. doi:10.1097/01.ijg.0000196654.77836.61.
   PubMed Web of Science ®Google Scholar